Stay updated on Imsidolimab for Palmoplantar Pustulosis Clinical Trial
Sign up to get notified when there's something new on the Imsidolimab for Palmoplantar Pustulosis Clinical Trial page.

Latest updates to the Imsidolimab for Palmoplantar Pustulosis Clinical Trial page
- ChecktodayChange DetectedThe study identifiers now include '2017 ( U.S. NIH Grant/Contract )', alongside the existing ANB019-003 and the EudraCT number (2017-004022-15).SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision is applied (v3.6.5), replacing the previous v3.6.4 revision. This indicates a backend update to the page's versioning or content management, likely addressing maintenance or internal improvements rather than visible content changes.SummaryDifference0.0%

- Check29 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a minor site or CMS update for the study details page; this does not modify study information or displayed content.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.3, indicating a newer build of the page. This update reflects metadata/version control rather than changes to the study content or displayed data.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page now indicates recruitment is closed and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). It also standardizes the Intervention/Treatment heading formatting and updates the revision to v3.6.0 (from v3.5.5).SummaryDifference0.3%

- Check78 days agoChange DetectedThe page revision badge was updated from v3.5.4 to v3.5.5, indicating a new version of the ClinicalTrials.gov page. This typically reflects minor updates or fixes to the page rather than changes to the study data or outcomes.SummaryDifference0.0%

Stay in the know with updates to Imsidolimab for Palmoplantar Pustulosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Imsidolimab for Palmoplantar Pustulosis Clinical Trial page.